Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 11-2000 | |
| Sales | 1,274 | 7,661 | 11,917 | 5,297 | 903 |
| Cost of Goods | N/A | N/A | 686 | 1,025 | 681 |
| Gross Profit | N/A | N/A | 11,231 | 4,272 | 222 |
| Operating Expenses | 24,432 | 18,878 | 12,774 | 11,802 | 6,962 |
| Operating Income | -23,159 | -11,217 | -1,543 | -7,530 | -6,740 |
| Other Income | 602 | -3,303 | 1,249 | 180 | 469 |
| Pre-tax Income | -22,556 | -14,520 | -294 | -7,349 | -6,271 |
| Income Tax | 3 | 126 | 72 | 55 | 14 |
| Net Income Continuous | -22,560 | -14,646 | -366 | -7,405 | -6,285 |
| Net Income | $-22,560 | $-14,646 | $-366 | $-7,405 | $-6,285 |
| EPS Basic Total Ops | -0.30 | -0.21 | -0.01 | -0.14 | -0.17 |
| EPS Basic Continuous Ops | -0.30 | -0.21 | -0.01 | -0.14 | -0.17 |
| EPS Diluted Total Ops | -0.30 | -0.21 | -0.01 | -0.14 | -0.17 |
| EPS Diluted Continuous Ops | -0.30 | -0.21 | -0.01 | -0.14 | -0.17 |
| EBITDA(a) | $-20,832 | $-9,829 | $-862 | $-7,199 | $-6,329 |